Nihon Kohden to Establish New Clinical Test Reagent Subsidiary in Italy.Tokyo Tokyo (tō`kēō), city (1990 pop. 8,163,573), capital of Japan and of Tokyo prefecture, E central Honshu, at the head of Tokyo Bay. , Japan, Mar 1, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Nihon Kohden has decided to establish a new subsidiary in Italy, Nihon Kohden Firenze, s.r.l. To be capitalized Capitalized Recorded in asset accounts and then depreciated or amortized, as is appropriate for expenditures for items with useful lives longer than one year. at approximately 1.2 million euros, the new subsidiary will manufacture and sell Nihon Kohden's proprietary clinical test reagents, such as dilutive solutions and reagents for hemolysis hemolysis (hĭmŏl`ĭsĭs), destruction of red blood cells in the bloodstream. Although new red blood cells, or erythrocytes, are continuously created and old ones destroyed, an excessive rate of destruction sometimes occurs. tests. Full-scale operations will begin in April. With this move, Nihon Kohden aims to steadily supply those products to overseas markets and double overseas sales for blood cell counters and related agents from 1.4 billion yen (US $12 million) over the next three years. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion